Hashimoto K - Search Results

1

Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol.

Sasaki H, Hashimoto K, Inada T, Fukui S, Iyo M. Sasaki H, et al. Among authors: hashimoto k. Eur J Pharmacol. 1995 Aug 25;282(1-3):71-6. doi: 10.1016/0014-2999(95)00278-s. Eur J Pharmacol. 1995. PMID: 7498291

2

Identification of a transcriptional regulatory factor for human aromatase cytochrome P450 gene expression as nuclear factor interleukin-6 (NF-IL6), a member of the CCAAT/enhancer-binding protein family.

Toda K, Akira S, Kishimoto T, Sasaki H, Hashimoto K, Yamamoto Y, Sagara Y, Shizuta Y. Toda K, et al. Among authors: hashimoto k. Eur J Biochem. 1995 Jul 15;231(2):292-9. doi: 10.1111/j.1432-1033.1995.tb20699.x. Eur J Biochem. 1995. PMID: 7635140 Free article.

3

Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.

Sasaki H, Hashimoto K, Maeda Y, Inada T, Kitao Y, Fukui S, Iyo M. Sasaki H, et al. Among authors: hashimoto k. Life Sci. 1995;56(25):PL443-7. doi: 10.1016/0024-3205(95)00218-u. Life Sci. 1995. PMID: 7791505

4

[Spinocerebellar ataxia 1--clinical study of 17 patients in a large pedigree].

Sasaki H, Wakisaka A, Koyama T, Hamada T, Shima K, Tashiro K, Hashimoto K, Miyagishi T. Sasaki H, et al. Among authors: hashimoto k. No To Shinkei. 1993 Jun;45(6):502-8. No To Shinkei. 1993. PMID: 8363844 Japanese.

5

Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists.

Tomitaka S, Hashimoto K, Narita N, Minabe Y, Tamura A. Tomitaka S, et al. Among authors: hashimoto k. Eur J Pharmacol. 1995 Oct 16;285(2):207-11. doi: 10.1016/0014-2999(95)00504-e. Eur J Pharmacol. 1995. PMID: 8566141

6

Lack of neuroprotective effect of sigma receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain.

Narita N, Hashimoto K, Iyo M, Minabe Y, Yamazaki K. Narita N, et al. Among authors: hashimoto k. Eur J Pharmacol. 1995 Oct 6;293(3):277-80. doi: 10.1016/s0922-4106(05)80055-0. Eur J Pharmacol. 1995. PMID: 8666047

7

Clinical features and natural history of spinocerebellar ataxia type 1.

Sasaki H, Fukazawa T, Yanagihara T, Hamada T, Shima K, Matsumoto A, Hashimoto K, Ito N, Wakisaka A, Tashiro K. Sasaki H, et al. Among authors: hashimoto k. Acta Neurol Scand. 1996 Jan;93(1):64-71. doi: 10.1111/j.1600-0404.1996.tb00173.x. Acta Neurol Scand. 1996. PMID: 8825276

8

Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram.

Iyo M, Bi Y, Hashimoto K, Inada T, Fukui S. Iyo M, et al. Among authors: hashimoto k. Eur J Pharmacol. 1996 Sep 26;312(2):163-70. doi: 10.1016/0014-2999(96)00479-7. Eur J Pharmacol. 1996. PMID: 8894591

9

Lack of neuroprotective effect of sigma receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain.

Narita N, Hashimoto K, Iyo M, Minabe Y, Yamazaki K. Narita N, et al. Among authors: hashimoto k. Ann N Y Acad Sci. 1996 Oct 31;801:199-204. doi: 10.1111/j.1749-6632.1996.tb17442.x. Ann N Y Acad Sci. 1996. PMID: 8959034 No abstract available.

10

Does an increase of cyclic AMP prevent methamphetamine-induced behavioral sensitization in rats?

Iyo M, Bi Y, Hashimoto K, Tomitaka SI, Inada T, Fukui S. Iyo M, et al. Among authors: hashimoto k. Ann N Y Acad Sci. 1996 Oct 31;801:377-83. doi: 10.1111/j.1749-6632.1996.tb17458.x. Ann N Y Acad Sci. 1996. PMID: 8959050 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,929 results

Search Page

Filters